Immunofluorescence assay data exhibited that the amount of LC3 fluorescent dots was remarkably increased in HCC cells with the combination treatment of PYCR1 siRNA and SK exposure for 48 h than an only single treatment (Figure 6a). Here, MAP1LC3A is linked to hepatocellular carcinoma.